Noncompaction cardiomyopathy medical therapy: Difference between revisions
No edit summary |
|||
| Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
The management of NCC is similar to that of other cardiomyopathies and includes the use of [[angiotensin-converting enzyme|ACE inhibitors]], [[Beta blocker|beta blockers]] and [[aspirin]] | The management of NCC is similar to that of other cardiomyopathies and includes the use of [[angiotensin-converting enzyme|ACE inhibitors]], [[Beta blocker|beta blockers]] and [[aspirin]]. | ||
In severe NCC cases, in which severe [[heart failure]] has developed, a [[heart transplant]] may be necessary. | In severe NCC cases, in which severe [[heart failure]] has developed, a [[heart transplant]] may be necessary. | ||
==Antiplatelet Therapy== | |||
Given the risk of [[embolization]], these patients are generally treated with prophylactic [[aspirin]]. | Given the risk of [[embolization]], these patients are generally treated with prophylactic [[aspirin]]. | ||
==Beta Blockade== | |||
NCC is assocatiated with an increased risk of arrhythmias including ventricular tachyarrhythmias. Beta blockade may reduce this risk. | |||
==Automatic Implantable Cardiac Defibrillator (AICD)== | |||
Implantation of an [[automatic internal cardiac defibrillator]] [[AICD]] may be appropriate in patients who are deemed to be at increased risk of [[sudden cardiac death]]. A small study from the Netherlands identified young females with [[premature ventricular contractions]] ([[PVCs]]) at risk of [[sudden death]]<ref>[http://spo.escardio.org/eslides/view.aspx?eevtid=33&fp=4147]</ref>. | |||
==References== | ==References== | ||
Revision as of 11:10, 6 August 2011
|
Noncompaction Cardiomyopathy Microchapters |
|
Pathophysiology |
|---|
|
Differentiating Noncompaction Cardiomyopathy from other Diseases |
|
Diagnosis |
|
Treatment |
|
Noncompaction cardiomyopathy medical therapy On the Web |
|
Risk calculators and risk factors for Noncompaction cardiomyopathy medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]
Overview
The management of NCC is similar to that of other cardiomyopathies and includes the use of ACE inhibitors, beta blockers and aspirin.
In severe NCC cases, in which severe heart failure has developed, a heart transplant may be necessary.
Antiplatelet Therapy
Given the risk of embolization, these patients are generally treated with prophylactic aspirin.
Beta Blockade
NCC is assocatiated with an increased risk of arrhythmias including ventricular tachyarrhythmias. Beta blockade may reduce this risk.
Automatic Implantable Cardiac Defibrillator (AICD)
Implantation of an automatic internal cardiac defibrillator AICD may be appropriate in patients who are deemed to be at increased risk of sudden cardiac death. A small study from the Netherlands identified young females with premature ventricular contractions (PVCs) at risk of sudden death[1].